Latest Articles
Proteomics secures Australian patent for endometriosis test - SMH.com.au
Proteomics secures Australian patent for endometriosis test SMH.com.au
Published: Aug. 13, 2026, 5:04 a.m.
Proteomics International Laboratories Secures Australian Patent Acceptance for PromarkerEndo - smallcaps.com.au
Proteomics International Laboratories Secures Australian Patent Acceptance for PromarkerEndo smallcaps.com.au
Published: Aug. 13, 2026, 4:16 a.m.
Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test - kalkine.com.au
Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test kalkine.com.au
Published: Aug. 12, 2026, 11:15 p.m.
Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test - Kalkine
Proteomics International Receives Australian Patent Acceptance for PromarkerEndo Endometriosis Blood Test Kalkine
Published: Aug. 12, 2026, 11:15 p.m.
Alex De Minaur V Andrey Rublev Extended Highlights | Australian Open 2024 Fourth Round Blue Lights (mfk271fnSA) - Mshale
Alex De Minaur V Andrey Rublev Extended Highlights | Australian Open 2024 Fourth Round Blue Lights (mfk271fnSA) Mshale
Published: Aug. 12, 2026, 1:26 p.m.
Missing the mark: Census 2026 ‘fails to ask’ Australia’s big questions - Herald Sun
Missing the mark: Census 2026 ‘fails to ask’ Australia’s big questions Herald Sun
Published: Aug. 11, 2026, 8:32 p.m.
New Norwood business promises women ‘more than medication’ - InDaily South Australia
New Norwood business promises women ‘more than medication’ InDaily South Australia
Published: Aug. 10, 2026, 12:29 a.m.
A drug for endometriosis and breast cancer is being pulled from Australia - RUSSH
A drug for endometriosis and breast cancer is being pulled from Australia RUSSH
Published: Aug. 5, 2026, 8:36 a.m.
H.C. Wainwright cuts Karyopharm stock rating on trial miss By Investing.com - Investing.com Australia
H.C. Wainwright cuts Karyopharm stock rating on trial miss By Investing.com Investing.com Australia
Published: July 31, 2026, 11:35 a.m.
AstraZeneca Reverses Decision to Pull Vital Cancer Drug from Australian Market - streamlinefeed.co.ke
AstraZeneca Reverses Decision to Pull Vital Cancer Drug from Australian Market streamlinefeed.co.ke
Published: July 30, 2026, 7:54 a.m.
Link copied to clipboard!